# Bacteriophages in Addition to Antibiotics for the Treatment of Patients With Infective Endocarditis

> **NCT06870409** · PHASE3 · RECRUITING · sponsor: **University Clinical Hospital na V.V.Vinogradov (branch of RUDN university na Patrice Lumumba)** · enrollment: 30 (estimated)

## Conditions studied

- Endocarditis, Bacterial

## Interventions

- **DRUG:** Bacteriophage

## Key facts

- **NCT ID:** NCT06870409
- **Lead sponsor:** University Clinical Hospital na V.V.Vinogradov (branch of RUDN university na Patrice Lumumba)
- **Sponsor class:** OTHER
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** RECRUITING
- **Start date:** 2025-02-05
- **Primary completion:** 2028-02-05
- **Final completion:** 2029-02-05
- **Target enrollment:** 30 (ESTIMATED)
- **Last updated:** 2026-03-19


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06870409

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06870409, "Bacteriophages in Addition to Antibiotics for the Treatment of Patients With Infective Endocarditis". Retrieved via AI Analytics 2026-06-08 from https://api.ai-analytics.org/clinical/NCT06870409. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*